Anti-EGFR monoclonal antibody-Y-90/Re-188
Alternative Names: RadioTheraCIM; RadioTheraCIM h-R3; Rhenium 188 TheraCIM; Yttrium 90 RadioTheraCIMLatest Information Update: 17 Jan 2011
At a glance
- Originator CIMYM
- Class Antineoplastics; Monoclonal antibodies; Radiopharmaceuticals
- Mechanism of Action Epidermal growth factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Glioma
Most Recent Events
- 17 Jan 2011 Discontinued - Phase-I for Glioma in Cuba (unspecified route)
- 17 Jan 2011 Discontinued - Phase-I for Glioma in Italy (unspecified route)
- 13 Sep 2005 This compound is still in active development